Homatropine
Composition
This Formulation contains homatropine methylbromide as a active pharmaceutical ingrediant.
Indications
Used for the symptomatic relief of cough.
Side effects
Common side effects include dizziness, drowsiness, nausea, constipation, and dry mouth.
Precautions
Cautiously used with the patients respiratory disorders, liver or kidney impairment.
Contraindications
Contraindicated in patients with severe respiratory depression, acute or severe bronchial asthma, paralytic ileus.
Dosage and administration
1.5 mg/5 mg 1 tablet per day, As directed by physician
Countries
United states, canada, UK
Available Forms
Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai